Acasti Pharma Statistics

Total Valuation

Acasti Pharma has a market cap or net worth of $33.16 million. The enterprise value is $14.46 million.

Market Cap	33.16M
Enterprise Value	14.46M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

Acasti Pharma has 10.14 million shares outstanding. The number of shares has increased by 39.68% in one year.

Shares Outstanding	10.14M
Shares Change (YoY)	+39.68%
Shares Change (QoQ)	-4.90%
Owned by Insiders (%)	27.98%
Owned by Institutions (%)	5.47%
Float	4.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.57
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.86

Current Ratio	7.86
Quick Ratio	7.62
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -18.56% and return on invested capital (ROIC) is -13.44%.

Return on Equity (ROE)	-18.56%
Return on Assets (ROA)	-11.62%
Return on Capital (ROIC)	-13.44%
Revenue Per Employee	n/a
Profits Per Employee	-$357,719
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.27M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.52
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	26,139

Short Selling Information

Short Interest	128,931
Short Previous Month	3,862
Short % of Shares Out	1.61%
Short % of Float	n/a
Short Ratio (days to cover)	3.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.27M
Pretax Income	-13.71M
Net Income	-11.45M
EBITDA	-13.27M
EBIT	-13.27M
Earnings Per Share (EPS)	-$1.10

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	19.41M
Total Debt	n/a
Net Cash	19.41M
Net Cash Per Share	$1.91
Equity (Book Value)	59.36M
Book Value Per Share	5.85
Working Capital	17.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.69 million and capital expenditures -$22,000, giving a free cash flow of -$9.71 million.

Operating Cash Flow	-9.69M
Capital Expenditures	-22,000
Free Cash Flow	-9.71M
FCF Per Share	-$0.96

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Acasti Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.68%
Shareholder Yield	-39.68%
Earnings Yield	-33.79%
FCF Yield	-28.67%

Analyst Forecast

The average price target for Acasti Pharma is $10.00, which is 205.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	205.81%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 10, 2023. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date	Jul 10, 2023
Split Type	Reverse
Split Ratio	0.1666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1